The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to ...

Investing.com -- Biohaven (NYSE:BHVN) stock fell 44% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application for VYGLXIA ...

Biohaven (BHVN) announced that it has received a complete response letter from the FDA for the new drug application seeking approval of Vyglxia ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range ...

Graves' disease is a disease in which thyroid function is excessively elevated due to an autoimmune response. Anti-thyroid ...

In Kentucky, a second wild deer has been confirmed with chronic wasting disease, a fatal neurologic disease that infects deer, elk and moose, but not people, ...

From weight gain and iodine to pregnancy and exercise, a thyroid expert busts 15 persistent myths about diagnosis, symptoms, ...

Autoimmune diseases are on the rise in the U.S., with as many as 50 million Americans affected. Learn what causes them—and which symptoms could help pinpoint your problem.